Leading the revolution in vaccine technology

Renowned scientists and entrepreneurs unite to create a unique platform for rapid development of highly versatile and efficient vaccines.

Covid-19 Vaccine Laboratory

About us

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.


The discovery of dendritic cells’ role in adaptative immunity system lead to a Nobel Prize in 2011.
Ten years of research later, 3 vaccines are entering clinical trial in 2021-2022. 

Press releases

June 21, 2021

Press release

Biotech start-up LinKinvax is created to accelerate the development, clinical trial and market access of a unique and innovative vaccine platform
May 26, 2021

Press release

LinKinVax-Labex VRI consortium secures 31 M€ in public funding to develop a booster vaccine against COVID-19

Interested in our project?